Serum levels of irisin and nesfatin-1 in multiple sclerosis

Serum levels of irisin and nesfatin-1 in multiple sclerosis

ABSTRACT Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune chronic neurological disease. Currently, there are no effective serum biomarkers to verify MS diagnosis, to assess disease prognosis, and evaluate response to MS treatment. Objective: The present stu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mustafa ALTAŞ, Ali Ulvi UCA, Turan AKDAĞ, Faruk Ömer ODABAŞ, Osman Serhat TOKGÖZ
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2022-02-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Multiple Sclerosis Irisin Nesfatin-1 Inflammation Apoptosis Oxidative Stress
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022005003204&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
by: Ali Al-Sajaad Mohammed Al-Azzawi, et al.
Published: (2025-04-01)

Possible roles of sestrin2 in multiple sclerosis and its relationships with clinical outcomes
by: Faruk Omer ODABAS, et al.
Published: (2022-02-01)

The prevalence of bruxism and related factors in patients with multiple sclerosis: a comparative study
by: Faruk Ömer Odabas, et al.

THE RELATION OF SERUM NESFATIN-1 LEVELS WITH DISEASE SEVERITY AND COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS
by: Özlem Kandemir Alibakan, et al.
Published: (2024-07-01)

Nesfatin-1 as a crucial mediator of glucose homeostasis in the reptile, Hemidactylus flaviviridis
by: Krittika Dotania, et al.
Published: (2024-12-01)

Relationship between serum Nesfatin-1, Adiponectin, Resistin Concentration, and Obesity with Type 2 Diabetes Mellitus
by: Baydaa Ahmed Abed, et al.
Published: (2024-01-01)

The tissue distribution of nucleobindin-2/nesfatin-1 in the reproductive organs of bitches with regard to the animal’s age and body weight
by: Rybska Marta, et al.
Published: (2025-03-01)

Sabah ve Gece Yapılan Aerobik Egzersizin Antrenmanlı Deneklerde Serum İrisin Düzeyine Etkilerinin Belirlenmesi
by: Fatih Tan, et al.
Published: (2017-03-01)

Nesfatin-1 expression and blood plasma concentration in female dogs suffering from cystic endometrial hyperplasia and pyometra and its possible interaction with phoenixin-14
by: Marta Rybska, et al.
Published: (2024-10-01)

Nesfatin-1 as a Potential Biomarker for Ischemic Stroke: A Case-Controlled Study of a Comparative Analysis of Patients with and Without Internal Carotid Artery Stenosis
by: Şennur Delibaş Kati, et al.
Published: (2025-03-01)

Evaluation of upper extremity ataxia through image processing in individuals with multiple sclerosis
by: Fatma Erdeo, et al.
Published: (2021-12-01)

The effect of breast milk nesfatin-1 and ghrelin levels on growth in infants with SGA
by: Berna Eroğlu Filibeli, et al.
Published: (2022-04-01)

Study on changes in serum irisin level in free-flap transplantation and the correlation of serum irisin level with flap blood flow
by: Xianyao Tao, et al.
Published: (2024-10-01)

Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes
by: Qizhuo Hou, et al.
Published: (2025-07-01)

Irisin and neuroinflammation: Challenges and opportunities
by: Erika Yolanda Hernández Sandoval, et al.
Published: (2024-12-01)

Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis
by: Weiping Xiao, et al.
Published: (2025-06-01)

Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01)

The Association Between Myokines, Inflammation, and Nutritional Status in Patients with Multiple Sclerosis
by: Natalia Mogiłko, et al.
Published: (2025-05-01)

Effect of 12 Weeks of Combined Training on the Serum Levels of Nesfatin-1 and Some Liver Enzymes in Men with Non-Alcoholic Fatty Liver Disease
by: Hadi Goudarzi, et al.
Published: (2024-05-01)

Correlation of irisin with lipid profile in type 2 diabetes mellitus
by: Wahengbam Diana Devi, et al.
Published: (2025-02-01)

Irisin protects against cerebral ischemia reperfusion injury in a SIRT3-dependent manner
by: Yushuang Cong, et al.
Published: (2025-04-01)

Serum irisin is positively associated with adiposity markers in obese women after single-session exercise-induced
by: Bayu Agung Pramono Pramono, et al.
Published: (2024-09-01)

Cloning of nucleobindin-2/Nesfatin-1 gene and its differential expression in diencephalon and hepatopancreas of Chinese sucker (Myxocyprinus asiaticus)
by: SU Shiping, et al.
Published: (2021-10-01)

Potential effect of Irisin on sarcopenia: a systematic review
by: Yixiao Chen, et al.
Published: (2025-05-01)

The relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus
by: Robab Beigom Aboutorabi, et al.
Published: (2025-06-01)

Expression and Clinical Significance of Irisin in Serum and Placenta Tissues of Pregnant Women with Severe Preeclampsia
by: Ren Y, et al.
Published: (2025-05-01)

Preptin and Irisin as a Metabolic Biomarkers in Juvenile Diabetes
by: Zeina Amer Ajam, et al.
Published: (2025-04-01)

Evaluation of structural-functional changes of the left ventricular myocardium in patients with arterial hypertension and obesity by the level of irisin
by: O. V. Shaparenko, et al.
Published: (2019-02-01)

Irisin alleviated sepsis via enhancing macrophage phagocytosis and reducing inflammation levels
by: Zeen Gong, et al.
Published: (2025-08-01)

Irisin Prevents the Effects of Simulated Microgravity on Bone and Muscle Differentiation Markers
by: Lorenzo Sanesi, et al.
Published: (2025-07-01)

The effect of periodontal health and disease on interleukin 1β and nesfatin-1 levels in gingival crevicular fluid: A cross-sectional study
by: Meral Uzunkaya, et al.
Published: (2024-07-01)

IRISIN, OBESITY AND TYPE II DIABETES MELLITUS
by: Zainab Fathi, et al.
Published: (2025-03-01)

The acute response of irisin to resistance and endurance exercise at both lower and higher intensities in healthy older adults
by: James E. Newman, et al.
Published: (2025-10-01)

Understanding the Role of Irisin in Longevity and Aging: A Narrative Review
by: Ana I. Plácido, et al.
Published: (2025-01-01)

Irisin: Emerging Therapeutic Targets for Cognitive Impairment-Related Diseases
by: Mei Ma, et al.
Published: (2025-01-01)

The effect of acute exercise and gender on the levels of irisin in elite athletes
by: Ş. Arıkan
Published: (2018-12-01)

The role of Irisin in modulating hypoxia-related disorders: New insights and implications for cancer therapy
by: Ghazaleh Khalili-Tanha, et al.
Published: (2025-06-01)

Association between circulating irisin level and depression: a systematic review and meta-analysis
by: Chengyan Han, et al.
Published: (2025-12-01)

Irisin restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis via regulating microglia activation
by: Qiu-Xia Zhang, et al.
Published: (2025-04-01)

Examining changes in serum levels of Irisin and Brain-Derived Neurotrophic Factor in inactive middle-aged men in two phases of training and detraining
by: Rezvan Afahar, et al.
Published: (2025-07-01)